CEZIBOE 0.25 mg, solution for injection in a pre-filled syringe syringe, 1 ml
Active ingredients: Cetrorelix monoacetate, Cetrorelix
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEZIBOE 0,25 mg, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 1 ml
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65669398CIP73021950CIP133400930219508Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉTRORÉLIX BASEsolution | 0,25 mg · 1 mL de solution | FT |
| CÉTRORÉLIX (ACÉTATE DE)solution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.